These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 9740697

  • 21. Radical surgery after neoadjuvant intra-arterial chemotherapy in stage IIIb squamous cell carcinoma of the cervix.
    Sugiyama T, Nishida T, Muraoka Y, Tokuda T, Kuromatsu H, Fujiyoshi K, Yakushiji M, Edamitu O, Haynbuchi N.
    Int Surg; 1999; 84(1):67-73. PubMed ID: 10421022
    [Abstract] [Full Text] [Related]

  • 22. [Chemotherapy of cancers of the uterine cervix with a combination of bleomycin, mitomycin, cisplatin and etoposide].
    Chauvergne J, Héron JF, Mayer F, Charrot-Chinet P, Toulouse C.
    Bull Cancer; 1993 Jan; 80(1):70-9. PubMed ID: 7515729
    [Abstract] [Full Text] [Related]

  • 23. Prolonged oral etoposide in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study.
    Rose PG, Blessing JA, Van Le L, Waggoner S.
    Gynecol Oncol; 1998 Aug; 70(2):263-6. PubMed ID: 9740702
    [Abstract] [Full Text] [Related]

  • 24. Determinants of response to a cisplatin-based regimen as neoadjuvant chemotherapy in stage IB-IIB invasive cervical cancer.
    Bolis G, van Zainten-Przybysz I, Scarfone G, Zanaboni F, Scarabelli C, Tateo S, Calabrese M, Parazzini F.
    Gynecol Oncol; 1996 Oct; 63(1):62-5. PubMed ID: 8898170
    [Abstract] [Full Text] [Related]

  • 25. Clinical efficacy of modified preoperative neoadjuvant chemotherapy in the treatment of locally advanced (stage IB2 to IIB) cervical cancer: randomized study.
    Chen H, Liang C, Zhang L, Huang S, Wu X.
    Gynecol Oncol; 2008 Sep; 110(3):308-15. PubMed ID: 18606439
    [Abstract] [Full Text] [Related]

  • 26. [Preoperative concurrent radiation therapy and chemotherapy for operable bulky carcinomas of uterine cervix stages IB2, IIA, and IIB with proximal parametrial invasion].
    Lerouge D, Touboul E, Lefranc JP, Uzan S, Jannet D, Moureau-Zabotto L, Genestie C, Antoine M, Jamali M.
    Cancer Radiother; 2004 Jun; 8(3):168-77. PubMed ID: 15217584
    [Abstract] [Full Text] [Related]

  • 27. Chemotherapy of advanced or recurrent cervical carcinoma with a consecutive low-dose cisplatin combined with bleomycin, vincristine, and mitomycin-C (consecutive low-dose BOMP).
    Shimizu Y.
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():359-77. PubMed ID: 10895181
    [Abstract] [Full Text] [Related]

  • 28. [Evaluation of neoadjuvant chemotherapy for locally advanced cervical cancinoma].
    Cheng XD, Lü WG, Ye F, Chen HZ, Xie X.
    Zhonghua Fu Chan Ke Za Zhi; 2006 Feb; 41(2):95-8. PubMed ID: 16640856
    [Abstract] [Full Text] [Related]

  • 29. Preoperative concurrent radiation therapy and chemotherapy for bulky stage IB2, IIA, and IIB carcinoma of the uterine cervix with proximal parametrial invasion.
    Huguet F, Cojocariu OM, Levy P, Lefranc JP, Darai E, Jannet D, Ansquer Y, Lhuillier PE, Benifla JL, Seince N, Touboul E.
    Int J Radiat Oncol Biol Phys; 2008 Dec 01; 72(5):1508-15. PubMed ID: 18676093
    [Abstract] [Full Text] [Related]

  • 30. A phase I study of paclitaxel, etoposide, and cisplatin in extensive stage small cell lung cancer.
    Kelly K, Pan Z, Wood ME, Murphy J, Bunn PA.
    Clin Cancer Res; 1999 Nov 01; 5(11):3419-24. PubMed ID: 10589753
    [Abstract] [Full Text] [Related]

  • 31. CD44 isoform 6 (CD44v6) is a prognostic indicator of the response to neoadjuvant chemotherapy in cervical carcinoma.
    Costa S, Terzano P, Bovicelli A, Martoni A, Angelelli B, Santini D, Ceccarelli C, Lipponen P, Erzén M, Syrjänen S, Syrjänen K.
    Gynecol Oncol; 2001 Jan 01; 80(1):67-73. PubMed ID: 11136572
    [Abstract] [Full Text] [Related]

  • 32. Neoadjuvant treatment of locally advanced carcinoma of the uterine cervix with epirubicin, paclitaxel and cisplatin.
    D'Agostino G, Distefano M, Greggi S, Salerno M, Ferrandina G, Poerio A, Mancuso S, Scambia G.
    Cancer Chemother Pharmacol; 2002 Mar 01; 49(3):256-60. PubMed ID: 11935219
    [Abstract] [Full Text] [Related]

  • 33. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
    Häberle B, Bode U, von Schweinitz D.
    Klin Padiatr; 2003 Mar 01; 215(3):159-65. PubMed ID: 12778356
    [Abstract] [Full Text] [Related]

  • 34. Phase II trial on neoadjuvant intravenous and trans-uterine arterial chemotherapy for locally advanced bulky cervical adenocarcinoma.
    Tsubamoto H, Maeda H, Kanazawa R, Ito Y, Ohama N, Hori M, Ikeda Y, Kato T, Sakane R, Hirota S.
    Gynecol Oncol; 2013 Apr 01; 129(1):129-34. PubMed ID: 23333929
    [Abstract] [Full Text] [Related]

  • 35. Results of a phase II trial of combined chemotherapy for patients with diffuse malignant mesothelioma of the pleura.
    Kasseyet S, Astoul P, Boutin C.
    Cancer; 1999 Apr 15; 85(8):1740-9. PubMed ID: 10223568
    [Abstract] [Full Text] [Related]

  • 36. Concomitant chemobrachyradiotherapy with ifosfamide and cisplatin followed by consolidation chemotherapy for women with locally advanced carcinoma of the uterine cervix--final results of a prospective phase II-study.
    Vrdoljak E, Omrcen T, Novaković ZS, Jelavić TB, Prskalo T, Hrepić D, Hamm W.
    Gynecol Oncol; 2006 Nov 15; 103(2):494-9. PubMed ID: 16814371
    [Abstract] [Full Text] [Related]

  • 37. Induction with mitomycin C, doxorubicin, cisplatin and maintenance with weekly 5-fluorouracil, leucovorin for treatment of metastatic nasopharyngeal carcinoma: a phase II study.
    Hong RL, Sheen TS, Ko JY, Hsu MM, Wang CC, Ting LL.
    Br J Cancer; 1999 Aug 15; 80(12):1962-7. PubMed ID: 10471046
    [Abstract] [Full Text] [Related]

  • 38. Sequential chemoradiation therapy with vinorelbine, ifosfamide, and cisplatin in stage IIIB non-small cell lung cancer: a phase II study.
    Baldini E, Silvano G, Tibaldi C, Campoccia S, Cionini L, Conte P.
    Semin Oncol; 2000 Feb 15; 27(1 Suppl 1):28-32. PubMed ID: 10697041
    [Abstract] [Full Text] [Related]

  • 39. The outcome of advanced or recurrent non-squamous carcinoma of the uterine cervix after platinum-based combination chemotherapy.
    Kastritis E, Bamias A, Efstathiou E, Gika D, Bozas G, Zorzou P, Sarris K, Papadimitriou C, Dimopoulos MA.
    Gynecol Oncol; 2005 Nov 15; 99(2):376-82. PubMed ID: 16051322
    [Abstract] [Full Text] [Related]

  • 40. Para-aortic involvement and interest of para-aortic lymphadenectomy after chemoradiation therapy in patients with stage IB2 and II cervical carcinoma radiologically confined to the pelvic cavity.
    Delpech Y, Haie-Meder C, Rey A, Zafrani Y, Uzan C, Gouy S, Pautier P, Lhommé C, Duvillard P, Castaigne D, Morice P.
    Ann Surg Oncol; 2007 Nov 15; 14(11):3223-31. PubMed ID: 17713822
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.